We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 19.25 | 0.00 | 07:49:41 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 19.00 | 21.00 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | EUR 56.04M | EUR 16.12M | EUR 0.0237 | 8.12 | 130.97M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 19.25 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/2/2025 | 07:00 | UK RNS | hVIVO PLC RSV contract signed with Inhalon Biopharma |
| 31/1/2025 | 13:24 | UK RNS | hVIVO PLC Holding(s) in Company |
| 31/1/2025 | 07:00 | UK RNS | hVIVO PLC Holding(s) in Company |
| 29/1/2025 | 11:42 | ALNC |  hVIVO eyes double-digit revenue rise, announces new acquisition |
| 29/1/2025 | 07:01 | UK RNS | hVIVO PLC Acquisition: two Clinical Research Units from CRS |
| 29/1/2025 | 07:00 | UK RNS | hVIVO PLC Trading update |
| 27/1/2025 | 11:18 | ALNC | hVIVO stock rises in response to vaccine testing contract |
| 27/1/2025 | 07:00 | UK RNS | hVIVO PLC LOI signed for Phase 3 Whooping Cough trial |
| 21/1/2025 | 12:16 | ALNC | hVIVO subsidiary hLAB wins largest contract to date with US client |
| 21/1/2025 | 07:00 | UK RNS | hVIVO PLC £3.2m hLAB project |
Hvivo (HVO) Share Charts1 Year Hvivo Chart |
|
1 Month Hvivo Chart |
Intraday Hvivo Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 03/2/2025 | 07:59 | hVIVO plc | 9,341 |
| 30/1/2025 | 23:01 | Profit warning now likely | 7 |
| 15/8/2024 | 16:32 | HVIVO (litter free) | 56 |
| 10/4/2024 | 06:01 | HVIVO (litrer free) | 2 |
| 26/10/2022 | 07:49 | hVIVO plc | 2,750 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 02/2/2025 08:20 by Hvivo Daily Update Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 19.25p.Hvivo currently has 680,371,877 shares in issue. The market capitalisation of Hvivo is £130,971,586. Hvivo has a price to earnings ratio (PE ratio) of 8.12. This morning HVO shares opened at - |
Posted at 27/1/2025 08:49 by pogue HVO have a letter of intent for a Phase 3 trial of a whooping cough vaccine. This is big news as previously only Phase 2 trails have been done by HVO but now they clearly have been given authorisation to do Phase 3. Phase 3 trails are normally very expensive and time consuming for pharma companies as they have to get a large group of people to vacinate in an area where the disease is prevalent, not easy to find, and monitor them for upto a year. Challenge studies, which HVO is the world leader in by a country mile, means volunteers are kept in isolation and given a safe does of the disease after having been given the vaccine hence the trial is cheaper but crucially very quick, a few months till results are known at most. This is a whole new opportunity for HVO. Phase 3 trials can cost upto £100 million HVO charge £10+ million for a Challenge study. For a phase 3 one they will charge more but even at twice or three times the price it’s a bargain for a pharma and saves huge amounts of time which in the end is money.So where would you go for a Phase 3 trial, to an expensive time consuming field trials company or a isolation unit based cheaper and quicker challenge trials company. Obviously a company for those that have investment horizons of more than a few days but it is a money making dividend paying company and clearly undervalued. |
Posted at 14/1/2025 21:18 by protrader3 There is no doubt whatsoever that Cathal would have had better knowledge of HVO than any research Octopus could have carried out. Cathal dumped his entire holding just under 30p Octopus are averaging down with a 40 percent loss with share price sitting at 17p.I dread ro think where the share price would be if it wasn't for Octopus. It's quite frightening actually. A poor T/U in February and this share price is going to tank even further. Mo really needs to pull something special out of the bag here. |
Posted at 08/1/2025 15:38 by sikhthetech Yes, getting closer to my 10p target..Where are the 30p brigade? Trout, 1gw, Pierre, Supernumerary etc etc Surely given these have fallen 40%, they are loading up???? I see FAB was also pumped/dumped, as predicted. sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 07/1/2025 17:10 by sikhthetech The share price is closer to 10p than 30p, isn't it?sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 31/12/2024 15:31 by sikhthetech There you go, the company newsflow has been as I predicted a year ago!!!sp was 25.5p when I posted the post... sp now at 20.5p. This is despite the supposedly huge new facility, huge buying by IIs, supposedly huge new contracts, supposedly huge potential!!!! I said I wouldn't buy because they are being talked up and I don't see the potential... Glad I didn't listen to 1gw and his mates ramping at 30p. sikhthetech - 02 Jan 2024 - 12:01:49 - 5733 of 9118 hVIVO plc - HVO chica, Baldrick is right, those who traded have made more than those who just held. Facts: Look at the chart and actual sps. Last year, in Feb, the share price was 21.5p Also, hardly any movement year to year. Out of last 4 years, 3 years the share price ended the year 23-24p. The other, Dec 2022, which was whilst Mo was CEO, it was 10.2p. Dec 2020 22p Dec 2021 24p Dec 2022 10.20p Feb 2023 21.5p, Dec 2023 23.75p The current share price is still lower than it was 2.5yrs ago, when I 1st looked at these - coincidentally following a media tip!. The share price has been falling during the year to move back towards 23p-24p by year end. Media tips and the share price rises again only to fall again. I have traded these in the past but don't currently hold as I believe they are hyped. Mo has huge options which are due to exercise in a year, so this is being talked up. £173m Mcap for a company with expected £60m revenues!! |
Posted at 24/12/2024 09:27 by protrader3 The 52 week price range is 18p - 31p. It is surprising that the share price is currently sitting right at the lower end. Opened the year at 24.75p now over 20 percent down in 2024. The share price is currently at the same level as October 2020. I do worry that less than impressive results will end up with HVO dropping lower.Just goes to show that HVO is a traders share not a long term hold of you want to make money. |
Posted at 12/12/2024 11:58 by sikhthetech Chica"How low will the market take the share price" I think to around 10p The company newsflow has been as expected. Oh look, Nexn thread busy, HVO quiet. Looks like 1gw and his mates have moved back to ramping nexn, another with a highly questionable business model (their peers refuse to use the same business model) and several different name changes. The share price there has crashed multiple times over the years. How many multiple ids do you have 1gw? |
Posted at 11/12/2024 13:19 by bossyboss What will happen next .. who knows .. but if I'm right this could well happen .1.In February, they finally warn on 2025 and beyond and the share price will crash. In the two weeks following that there will be hell on and a stewards inquiry from all of the new institutions who bought in on the " trust me " words from Mo .They will want to know when Mo realised the contracts had dried up. One might argue it's been pretty obvious for a long time and also pretty obvious why it's been kept quiet for a while . I've seen this happen before, a few of the institutions will lose confidence in Mo and just want out as they will feel that they have been screwed. This will result in a further collapse in the share price . 3 . at that point I will be opening a large position again because I would expect a swift bid but probably at a price lower than the current share price. Just a thought .. been there seen it done it.. DYOR |
Posted at 11/12/2024 12:32 by sikhthetech Trout,"At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 20/11/2024 17:56 by malcolmz1 The problem is HVO share price is about to test 18p. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
